The vast majority of previous studies evaluating glucose tolerance in RTRs employed parameters of fasting insulin sensitivity, like the homeostasis model assessment of insulin resistance (HOMA-IR) or the quantitative insulin sensitivity check-index (QUICKI), but not of dynamic/glucose-stimulated insulin sensitivity and insulin secretion. The gene discussed is INS; the disease is Insulin resistance.